Begin typing into any of the search fields below to filter the list.
Have an event you would like to post? Submit it here.
|EVENT NAME||ORGANIZER NAME||START DATE||START TIME||END DATE||END TIME||EVENT WEBSITE||EVENT DESCRIPTION|
|Should Alexa Diagnose Alzheimer’s?: A Health Policy and Bioethics Consortium||Petrie-Flom Center for Health Law Policy, Biotechnology and Bioethics||02/11/2022||12:30 PM||2/11/2022||02:00 PM||Technology is now part of our lives in ways that were not possible only 10-20 years ago. Smart devices, like watches, phones, and speakers, can gather vast amounts of information about their users, often without the user’s knowledge or consent. As technology continues to improve, many of these devices may also be leveraged to serve diagnostic functions. Technologies such as Amazon’s Alexa and Google’s Assistant can ambiently and continually monitor a variety of information about an individual’s location, voice, and movement. As this technology merges with wearables, such as the Apple Watch or FitBit, it may become possible to diagnose a wide range of diseases, including Alzhiemer’s. But should it? To help answer that question, Dr. Barbara Evans and Dr. Jason Karlawish will discuss the medical, legal, and ethical implications of using such technology to diagnose diseases, such as Alzhiemer’s. Panelists Introduction: Carmel Shachar, Executive Director, Petrie-Flom Center Barbara Evans, Professor of Law and Stephen C. O’Connell Chair, Fredric G. Levin College of Law and Professor of Engineering, Herbert Wertheim College of Engineering, University of Florida Jason Karlawish, Professor of Medicine, Perelman School of Medicine at the University of Pennsylvania Moderator: David A. Simon, Research Fellow, Digital Home Health, Petrie-Flom Center The Health Policy and Bioethics Consortia is a monthly series that convenes two international experts from different fields or vantage points to discuss how biomedical innovation and health care delivery are affected by various ethical norms, laws, and regulations. They are organized by the Harvard Medical School Center for Bioethics and the Program on Regulation, Therapeutics, and Law (PORTAL) at Brigham and Women's Hospital, in collaboration with the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School. Support provided by the Oswald DeN. Cammann Fund at Harvard University.|
|Exporting Mayhem: Suing Gun Manufacturers in the US to Stop Violence in Mexico||Petrie-Flom Center for Health Law Policy, Biotechnology and Bioethics||02/17/2022||12:30 PM||2/17/2022||02:00 PM||In 2021, the Mexican government filed a ground-breaking suit in federal court in Boston, Massachusetts, against ten US gun manufacturers, accusing them of knowingly facilitating the sale of guns to drug cartels in Mexico. This is the first time that a foreign government has sued the makers of guns in the United States. For many in the US, the narrative of cartel violence in Mexico may point to lawlessness and ineffective oversight. But there is another story; over the last 15 years, homicides have tripled in Mexico and as many as 90% of the guns used in drug-related violence come from the United States. While gun laws in Mexico are extremely restrictive, cartels find it easy to purchase them in a border state, such as Texas or Arizona, and then smuggle those guns across the border. The suit makes a combination of novel arguments regarding the targeted marketing of guns to cartels, the lack of effective regulation regarding gun sales, and the applicability of federal legislation to a foreign government. This panel will combine discussion of the nature of public health crises created by gun violence in both the United States and Mexico; the legal rules regarding gun ownership and regulation; and the arguments being advanced in the specific litigation. Panelists Welcome: Carmel Shachar, Executive Director, Petrie-Flom Center Introduction: Alicia Ely Yamin, Senior Fellow in Global Health and Rights, The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School Opening remarks: Alejandro Celorio Alcántara, Legal Adviser/ Ministry of Foreign Affairs, Government of Mexico David Pérez Esparza, Director, National Center for Information, National System of Public Security, Government of Mexico Heidi Li Feldman, Professor of Law, Georgetown University Law Center and Director, Joint Degree in Law and Philosophy, Georgetown Law Daivd Hemenway, Professor of Health Policy, Director, Harvard Injury Control Research Center, Harvard University Steve Shadowen, Founding Partner, Hilliard & Shadowen LLP Sponsored by the Global Health and Rights Project (GHRP), a collaboration between the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School and the Global Health Education and Learning Incubator (GHELI) at Harvard University, the Mexico program at the David Rockefeller Center for Latin American Studies (DRCLAS) at Harvard University, and the Consulate General of Mexico in Boston.|
|Planetary Change is Driving New Patterns of Non-Communicable Disease||HSPH||01/05/2022||01:00 PM||01/05/2022||02:00 PM||The Departments of Environmental Health, Global Health and Population, Immunology and Infectious Diseases, and Nutrition, along with the Harvard University Center for the Environment, the Harvard Global Health Institute, and the Planetary Health Alliance warmly welcome Francesca Dominici, Pauline Scheelbeek and Philip Landrigan as the fourth speakers of the Planetary Health Colloquium Series.|
|Designing and Implementing AI Solutions for Health Care||Harvard Medical School||01/18/2022||1/27/2022||This Harvard Medical School Executive Education program will allow leaders across the ecosystem to gain insights into what it takes to successfully utilize AI in the unique cultural, economic and regulatory context of health care. Interactive sessions will address technical concepts as well as real-world implementation, with examples drawn from health care delivery/operations and drug development.|